Filing Flows

Filing Flows › Companies › P3 Health Partners › Report card

P3 Health Partners earnings report card

Every report on file against what analysts and the company itself expected, and what the stock did

Beat rate2 of 4 reports beat the EPS estimate

P3 Health Partners (PIII) beat the analysts' EPS estimate in 2 of its last 4 reports (50%), by -6.9% on average. On report days the stock moved 10.2% in either direction on median (largest 216.3%), rising 50% of the time. Next report: Nov 9, 2026, analysts expect EPS −$7.40.

Beat rate50% of 4
Average surprise-6.9%
Median move on the day±10.2%
Rose on the day50%
Next reportNov 9, 2026

Report by report

QuarterReportedEPS est.EPS reportedSurpriseGAAP EPSRevenue reportedStock, the dayvs market
Q2 2026Aug 10, 2026−$1.90−$0.63+66.8%−$0.63$386M+6.8%+7.2%
Q1 2026May 14, 2026−$3.50$0.32+109.1%$0.32$386M+216.3%+216.7%
Q4 2025Mar 26, 2026−$9.46−$23.02-143.2%—$385M-5.5%-2.0%
Q3 2025Nov 13, 2025−$6.04−$9.67-60.2%−$9.67$345M-10.2%-8.6%

Estimates and reported EPS are the Street's adjusted figures; GAAP EPS is from the filing (SEC XBRL). Revenue reported is from the company's filing. The stock's move is close to close around the report date (the close before it to the close of the session after), against SPY for the market column.

Charts

P3 Health Partners: EPS reported against the estimateP3 Health Partners: EPS reported against the estimateEstimateReported−$6.04−$9.67Q3 2025−$9.46−$23.02Q4 2025−$3.50$0.32Q1 2026−$1.90−$0.63Q2 2026
Latest (Q2 2026): Estimate −$1.90, Reported −$0.63.
PIII: the stock's move on each report dayPIII: the stock's move on each report dayQ2 2026+6.8%Q1 2026+216.3%Q4 2025-5.5%Q3 2025-10.2%
Close to close around the report, from the daily price history.

The earnings-day move

Over 4 reports the stock moved 10.2% on median on the day (close to close), the largest move 216.3%.

The next report: what to expect → P3 Health Partners: every quarter →

Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.